Clinical Trial

Comparing the Outcome of Buccal Midazolam and Intramuscular Midazolam in Children Presenting With Seizures.

Completed Phase 4
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial(Quasi Experimental) is to compare efficacy of oral midazolam over intra-muscular Midazolam in children suffering from seizures. The main question it aims to answer is: Does Buccal midazolam has a better efficacy as compared to intramuscular midazolam in children presenting with seizures? There will be two groups determined by randomisation and then one will be given buccal midazolam and other will will be administered IM Midazolam .The out come will be determined by the determining the cessation of seizures within 5 minutes duration achieved by administration of drug.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-31.
Trial Details
NCT Number NCT07626255
Lead Sponsor Pakistan Air Force (PAF) Hospital Islamabad
Conditions Seizure Disorder Generalized Tonic Clonic
Enrollment 90 participants
Start Date 2022-01-15
Primary Completion 2022-05-14 (estimated)
Study Completion 2022-06-14 (estimated)
Updated on ClinicalTrials.gov 2026-06-15